AmacaThera Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.23M

  • Investors
  • 17

AmacaThera General Information

Description

Developer of a hydrogel-based drug delivery platform designed to enable localized and sustained therapeutic delivery. The company offers temperature-responsive liquid-to-gel formulations for small molecules and biologics, enabling pharmaceutical and biotechnology companies to develop long-acting therapies with improved therapeutic performance, enhanced patient convenience, and reduced systemic exposure.

Contact Information

Website
www.amacathera.com
Formerly Known As
Hammock Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • MaRS Centre, West Tower, 661 University Avenue
  • Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • MaRS Centre, West Tower, 661 University Avenue
  • Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmacaThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A) 16-Oct-2023 $4.23M Completed Clinical Trials - Phase 1
13. Secondary Transaction - Private Completed Pre-Clinical Trials
12. Accelerator/Incubator 26-Oct-2022 Completed Pre-Clinical Trials
11. Later Stage VC 01-Jul-2022 Completed Pre-Clinical Trials
10. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
8. Later Stage VC (Series A) 22-Feb-2021 Completed Pre-Clinical Trials
7. Seed Round 03-Oct-2019 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Mar-2019 $65K Completed Pre-Clinical Trials
5. Accelerator/Incubator $65K Completed Pre-Clinical Trials
To view AmacaThera’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AmacaThera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a hydrogel-based drug delivery platform designed to enable localized and sustained therapeutic delivery. Th
Drug Discovery
Toronto, Canada
13 As of 2021

Boston, MA
 

Darien, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmacaThera Competitors (5)

One of AmacaThera’s 5 competitors is Elektrofi, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elektrofi Formerly VC-backed Boston, MA
Cytogel Pharma Venture Capital-Backed Darien, CT
Pacira BioSciences Formerly VC-backed Tampa, FL
Halozyme Therapeutics Formerly VC-backed San Diego, CA
Theron Pharmaceuticals Formerly VC-backed Sunnyvale, CA
You’re viewing 5 of 5 competitors. Get the full list »

AmacaThera Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

AmacaThera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026178644-A1 Hydrogel pharmaceutical compositions and their methods of use for treatment of cancer Pending 26-Feb-2025
WO-2026148415-A1 Hydrogel coated surgical meshes and uses thereof Pending 10-Jan-2025
WO-2026151990-A1 Hydrogel coated surgical meshes and uses thereof Pending 10-Jan-2025
WO-2026047519-A1 Hydrogel pharmaceutical compositions and their methods of use for treatment of cancer Pending 25-Aug-2024
WO-2023096899-A1 Hydrogel pharmaceutical compositions Inactive 24-Nov-2021 A61K9/06
To view AmacaThera’s complete patent history, request access »

AmacaThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmacaThera Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Innovation Factory (Hamilton) Accelerator/Incubator
Changrong Capital Venture Capital Minority
Canadian Entrepreneurs in Life Science Accelerator/Incubator
Canadian Technology Accelerator Accelerator/Incubator
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

AmacaThera FAQs

  • When was AmacaThera founded?

    AmacaThera was founded in 2015.

  • Where is AmacaThera headquartered?

    AmacaThera is headquartered in Toronto, Canada.

  • What is the size of AmacaThera?

    AmacaThera has 13 total employees.

  • What industry is AmacaThera in?

    AmacaThera’s primary industry is Drug Discovery.

  • Is AmacaThera a private or public company?

    AmacaThera is a Private company.

  • What is the current valuation of AmacaThera?

    The current valuation of AmacaThera is .

  • What is AmacaThera’s current revenue?

    The current revenue for AmacaThera is .

  • How much funding has AmacaThera raised over time?

    AmacaThera has raised $15.1M.

  • Who are AmacaThera’s investors?

    , Innovation Factory (Hamilton), Changrong Capital, Canadian Entrepreneurs in Life Science, and Canadian Technology Accelerator are 5 of 17 investors who have invested in AmacaThera.

  • Who are AmacaThera’s competitors?

    Elektrofi, Cytogel Pharma, Pacira BioSciences, Halozyme Therapeutics, and Theron Pharmaceuticals are competitors of AmacaThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process